Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry

Spiros D. Garbis, Stavros I. Tyritzis, Theodoros Roumeliotis, Panagiotis Zerefos, Eugenia G. Giannopoulou, Antonia Vlahou, Sophia Kossida, Jose Diaz, Stavros Vourekas, Constantin Tamvakopoulos, Kitty Pavlakis, Despina Sanoudou, Constantinos A. Constantinides

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

This study aimed to identify candidate new diagnosis and prognosis markers and medicinal targets of prostate cancer (PCa), using state of the art proteomics. A total of 20 prostate tissue specimens from 10 patients with benign prostatic hyperplasia (BPH) and 10 with PCa (Tumour Node Metastasis [TNM] stage T1-T3) were analyzed by isobaric stable isotope labeling (iTRAQ) and two-dimensional liquid chromatography-tandem mass spectrometry (2DLC-MS/MS) approaches using a hybrid quadrupole time-of-flight system (QqTOF). The study resulted in the reproducible identification of 825 nonredundant gene products (p ≤ 0.05) of which 30 exhibited up-regulation (≥ 2-fold) and another 35 exhibited down-regulation (≤0.5-fold) between the BPH and PCa specimens constituting a major contribution toward their global proteomic assessment. Selected findings were confirmed by immunohistochemical analysis of prostate tissue specimens. The proteins determined support existing knowledge and uncover novel and promising PCa biomarkers. The PCa proteome found can serve as a useful aid for the identification of improved diagnostic and prognostic markers and ultimately novel chemopreventive and therapeutic targets.

Original languageEnglish
Pages (from-to)3146-3158
Number of pages13
JournalJournal of Proteome Research
Volume7
Issue number8
DOIs
Publication statusPublished - 1 Aug 2008
Externally publishedYes

Fingerprint

Liquid chromatography
Tandem Mass Spectrometry
Liquid Chromatography
Amines
Mass spectrometry
Prostatic Neoplasms
Tissue
Proteome
Tumor Biomarkers
Isotopes
Labeling
Tumors
Genes
Prostatic Hyperplasia
Proteomics
Prostate
Therapeutics
Isotope Labeling
Proteins
Up-Regulation

Keywords

  • Biomarkers
  • iTRAQ
  • LC-MS
  • Prostate cancer
  • Proteomics

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. / Garbis, Spiros D.; Tyritzis, Stavros I.; Roumeliotis, Theodoros; Zerefos, Panagiotis; Giannopoulou, Eugenia G.; Vlahou, Antonia; Kossida, Sophia; Diaz, Jose; Vourekas, Stavros; Tamvakopoulos, Constantin; Pavlakis, Kitty; Sanoudou, Despina; Constantinides, Constantinos A.

In: Journal of Proteome Research, Vol. 7, No. 8, 01.08.2008, p. 3146-3158.

Research output: Contribution to journalArticle

Garbis, SD, Tyritzis, SI, Roumeliotis, T, Zerefos, P, Giannopoulou, EG, Vlahou, A, Kossida, S, Diaz, J, Vourekas, S, Tamvakopoulos, C, Pavlakis, K, Sanoudou, D & Constantinides, CA 2008, 'Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry', Journal of Proteome Research, vol. 7, no. 8, pp. 3146-3158. https://doi.org/10.1021/pr800060r
Garbis, Spiros D. ; Tyritzis, Stavros I. ; Roumeliotis, Theodoros ; Zerefos, Panagiotis ; Giannopoulou, Eugenia G. ; Vlahou, Antonia ; Kossida, Sophia ; Diaz, Jose ; Vourekas, Stavros ; Tamvakopoulos, Constantin ; Pavlakis, Kitty ; Sanoudou, Despina ; Constantinides, Constantinos A. / Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. In: Journal of Proteome Research. 2008 ; Vol. 7, No. 8. pp. 3146-3158.
@article{5578cc32d2f44640967ede0d1aa2b4b2,
title = "Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry",
abstract = "This study aimed to identify candidate new diagnosis and prognosis markers and medicinal targets of prostate cancer (PCa), using state of the art proteomics. A total of 20 prostate tissue specimens from 10 patients with benign prostatic hyperplasia (BPH) and 10 with PCa (Tumour Node Metastasis [TNM] stage T1-T3) were analyzed by isobaric stable isotope labeling (iTRAQ) and two-dimensional liquid chromatography-tandem mass spectrometry (2DLC-MS/MS) approaches using a hybrid quadrupole time-of-flight system (QqTOF). The study resulted in the reproducible identification of 825 nonredundant gene products (p ≤ 0.05) of which 30 exhibited up-regulation (≥ 2-fold) and another 35 exhibited down-regulation (≤0.5-fold) between the BPH and PCa specimens constituting a major contribution toward their global proteomic assessment. Selected findings were confirmed by immunohistochemical analysis of prostate tissue specimens. The proteins determined support existing knowledge and uncover novel and promising PCa biomarkers. The PCa proteome found can serve as a useful aid for the identification of improved diagnostic and prognostic markers and ultimately novel chemopreventive and therapeutic targets.",
keywords = "Biomarkers, iTRAQ, LC-MS, Prostate cancer, Proteomics",
author = "Garbis, {Spiros D.} and Tyritzis, {Stavros I.} and Theodoros Roumeliotis and Panagiotis Zerefos and Giannopoulou, {Eugenia G.} and Antonia Vlahou and Sophia Kossida and Jose Diaz and Stavros Vourekas and Constantin Tamvakopoulos and Kitty Pavlakis and Despina Sanoudou and Constantinides, {Constantinos A.}",
year = "2008",
month = "8",
day = "1",
doi = "10.1021/pr800060r",
language = "English",
volume = "7",
pages = "3146--3158",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "8",

}

TY - JOUR

T1 - Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry

AU - Garbis, Spiros D.

AU - Tyritzis, Stavros I.

AU - Roumeliotis, Theodoros

AU - Zerefos, Panagiotis

AU - Giannopoulou, Eugenia G.

AU - Vlahou, Antonia

AU - Kossida, Sophia

AU - Diaz, Jose

AU - Vourekas, Stavros

AU - Tamvakopoulos, Constantin

AU - Pavlakis, Kitty

AU - Sanoudou, Despina

AU - Constantinides, Constantinos A.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - This study aimed to identify candidate new diagnosis and prognosis markers and medicinal targets of prostate cancer (PCa), using state of the art proteomics. A total of 20 prostate tissue specimens from 10 patients with benign prostatic hyperplasia (BPH) and 10 with PCa (Tumour Node Metastasis [TNM] stage T1-T3) were analyzed by isobaric stable isotope labeling (iTRAQ) and two-dimensional liquid chromatography-tandem mass spectrometry (2DLC-MS/MS) approaches using a hybrid quadrupole time-of-flight system (QqTOF). The study resulted in the reproducible identification of 825 nonredundant gene products (p ≤ 0.05) of which 30 exhibited up-regulation (≥ 2-fold) and another 35 exhibited down-regulation (≤0.5-fold) between the BPH and PCa specimens constituting a major contribution toward their global proteomic assessment. Selected findings were confirmed by immunohistochemical analysis of prostate tissue specimens. The proteins determined support existing knowledge and uncover novel and promising PCa biomarkers. The PCa proteome found can serve as a useful aid for the identification of improved diagnostic and prognostic markers and ultimately novel chemopreventive and therapeutic targets.

AB - This study aimed to identify candidate new diagnosis and prognosis markers and medicinal targets of prostate cancer (PCa), using state of the art proteomics. A total of 20 prostate tissue specimens from 10 patients with benign prostatic hyperplasia (BPH) and 10 with PCa (Tumour Node Metastasis [TNM] stage T1-T3) were analyzed by isobaric stable isotope labeling (iTRAQ) and two-dimensional liquid chromatography-tandem mass spectrometry (2DLC-MS/MS) approaches using a hybrid quadrupole time-of-flight system (QqTOF). The study resulted in the reproducible identification of 825 nonredundant gene products (p ≤ 0.05) of which 30 exhibited up-regulation (≥ 2-fold) and another 35 exhibited down-regulation (≤0.5-fold) between the BPH and PCa specimens constituting a major contribution toward their global proteomic assessment. Selected findings were confirmed by immunohistochemical analysis of prostate tissue specimens. The proteins determined support existing knowledge and uncover novel and promising PCa biomarkers. The PCa proteome found can serve as a useful aid for the identification of improved diagnostic and prognostic markers and ultimately novel chemopreventive and therapeutic targets.

KW - Biomarkers

KW - iTRAQ

KW - LC-MS

KW - Prostate cancer

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=53049090352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53049090352&partnerID=8YFLogxK

U2 - 10.1021/pr800060r

DO - 10.1021/pr800060r

M3 - Article

VL - 7

SP - 3146

EP - 3158

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 8

ER -